A detailed history of Nomura Holdings Inc transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 23,578 shares of ESPR stock, worth $52,343. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,578
Holding current value
$52,343
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.02 - $3.02 $47,627 - $71,205
23,578 New
23,578 $63,000
Q4 2023

Feb 14, 2024

SELL
$0.73 - $3.08 $57,433 - $242,322
-78,676 Reduced 67.81%
37,345 $111,000
Q1 2023

May 15, 2023

SELL
$1.46 - $7.3 $106,985 - $534,929
-73,278 Reduced 38.71%
116,021 $184,000
Q4 2022

Feb 14, 2023

BUY
$5.09 - $8.5 $963,531 - $1.61 Million
189,299 New
189,299 $1.17 Million
Q4 2021

Feb 14, 2022

SELL
$4.81 - $11.92 $149,326 - $370,056
-31,045 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$11.34 - $21.37 $652,764 - $1.23 Million
-57,563 Reduced 64.96%
31,045 $369,000
Q2 2021

Aug 16, 2021

BUY
$19.4 - $28.71 $331,371 - $490,395
17,081 Added 23.88%
88,608 $1.88 Million
Q1 2021

May 17, 2021

SELL
$25.12 - $36.89 $5.46 Million - $8.02 Million
-217,291 Reduced 75.23%
71,527 $2 Million
Q4 2020

Feb 16, 2021

BUY
$24.2 - $35.76 $1.54 Million - $2.28 Million
63,818 Added 28.36%
288,818 $7.53 Million
Q1 2020

May 14, 2020

SELL
$27.44 - $73.84 $8.92 Million - $24 Million
-325,000 Reduced 59.09%
225,000 $7.08 Million
Q1 2019

May 14, 2019

BUY
$40.11 - $53.57 $3.42 Million - $4.57 Million
85,300 Added 18.36%
550,000 $22 Million
Q4 2018

Feb 14, 2019

BUY
$36.99 - $59.11 $6.83 Million - $10.9 Million
184,700 Added 65.96%
464,700 $21.3 Million
Q3 2018

Nov 14, 2018

BUY
$40.74 - $51.41 $1.22 Million - $1.54 Million
30,000 Added 12.0%
280,000 $12.7 Million
Q2 2018

Aug 14, 2018

BUY
$36.2 - $76.4 $8.87 Million - $18.7 Million
245,000 Added 4900.0%
250,000 $9.15 Million
Q1 2018

May 14, 2018

BUY
$65.94 - $80.76 $329,700 - $403,800
5,000 New
5,000 $362,000

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $148M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.